Important funding source for nation’s research on global health at risk from reduced aid budget
Global health initiatives that invest tens of millions of pounds in UK R&D each year are at risk of having their funding cut as Dominic Raab looks for savings in the UK’s aid budget.
Product development partnerships (PDPs) are non-profit organisations focused on developing medical products for diseases neglected by the pharmaceutical industry, such as malaria and drug-resistant TB. While the focus of such PDPs is largely on global health, they invest significant amounts in R&D carried out in the UK and internationally.
This article is only available to *Research Professional subscribers. If you are a subscriber you can read the article in full on researchprofessional.com
Alternatively, Pivot-RP users can log in and view the article via this link.